Cargando…
Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
Despite apparently having completed surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying the drivers of relapse, who benefits from a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174852/ https://www.ncbi.nlm.nih.gov/pubmed/35711845 http://dx.doi.org/10.7150/jca.69583 |